Synthesis and anti-HBV activity of carbocyclic nucleoside hybrids with salient features of entecavir and aristeromycin
A new carbocyclic nucleoside with the salient features of entecavir and aristeromycin identified as the anti-HBV lead candidate.
1997 ◽
Vol 41
(5)
◽
pp. 1082-1093
◽
Keyword(s):
2001 ◽
Vol 14
(04)
◽
pp. 179-184
◽
Keyword(s):